| Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence H Hampel, R Nisticò, NT Seyfried, AI Levey, E Modeste, P Lemercier, ... Ageing Research Reviews 69, 101346, 2021 | 95 | 2021 |
| Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT … C Babiloni, S Lopez, C Del Percio, G Noce, MT Pascarelli, R Lizio, ... Neurobiology of Aging 90, 43-59, 2020 | 40 | 2020 |
| In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease SJ Teipel, M Dyrba, PA Chiesa, F Sakr, I Jelistratova, S Lista, A Vergallo, ... Neurobiology of aging 93, 98-108, 2020 | 32 | 2020 |
| Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery H Hampel, A Vergallo, F Caraci, AC Cuello, P Lemercier, B Vellas, ... Neuropharmacology 185, 108081, 2021 | 30 | 2021 |
| Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study F Baldacci, S Lista, ML Manca, PA Chiesa, E Cavedo, P Lemercier, ... Alzheimer's research & therapy 12, 1-12, 2020 | 30 | 2020 |
| Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers A Vergallo, S Lista, P Lemercier, PA Chiesa, H Zetterberg, K Blennow, ... Neurobiology of aging 96, 22-32, 2020 | 22 | 2020 |
| MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints A Vergallo, S Lista, Y Zhao, P Lemercier, SJ Teipel, MC Potier, MO Habert, ... Translational psychiatry 11 (1), 78, 2021 | 21 | 2021 |
| Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD A Vergallo, M Houot, E Cavedo, P Lemercier, E Vanmechelen, A De Vos, ... Alzheimer's & Dementia 15 (10), 1274-1285, 2019 | 19 | 2019 |
| Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease H Depypere, A Vergallo, P Lemercier, S Lista, A Benedet, N Ashton, ... Alzheimer's & Dementia 19 (4), 1320-1330, 2023 | 16 | 2023 |
| Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases S Lista, A Vergallo, SJ Teipel, P Lemercier, FS Giorgi, A Gabelle, F Garaci, ... Ageing research reviews 84, 101819, 2023 | 14 | 2023 |
| Plasma β‐secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD A Vergallo, P Lemercier, E Cavedo, S Lista, E Vanmechelen, A De Vos, ... Alzheimer's & Dementia 17 (4), 629-640, 2021 | 13 | 2021 |
| Alzheimer Precision Medicine Initiative (APMI)(2021) Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence H Hampel, R Nistico, NT Seyfried, AI Levey, E Modeste, P Lemercier, ... Ageing Res Rev 69, 101346, 0 | 5 | |
| Alzheimer Precision Medicine Initiative (APMI)(2020) Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year followup … F Baldacci, S Lista, ML Manca, PA Chiesa, E Cavedo, P Lemercier, ... | 5 | |
| Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease P Lemercier, A Vergallo, S Lista, H Zetterberg, K Blennow, MC Potier, ... Neurobiology of Aging 107, 57-69, 2021 | 3 | 2021 |
| Biological mechanism-based neurology and psychiatry: a BACE1/2 and downstream pathway model H Hampel, G Caruso, R Nisticò, G Piccioni, NB Mercuri, FS Giorgi, ... Current Neuropharmacology 21 (1), 31, 2023 | 2 | 2023 |
| Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease P Lemercier, L Cleret de Langavant, J Hamet Bagnou, K Youssov, ... Journal of personalized medicine 12 (2), 174, 2022 | 2 | 2022 |
| Aging and sex impact plasma NFL and t-Tau trajectories in individuals at risk for Alzheimer’s disease F Baldacci, S Lista, ML Manca, P Lemercier, PA Chiesa, H Zetterberg, ... 2020 Alzheimer's Association International Conference, 2020 | 2 | 2020 |
| Aging and sex impact plasma NFL and t‐Tau trajectories in individuals at risk for Alzheimer’s disease: Biomarkers (non‐neuroimaging)/plasma/serum/urine biomarkers F Baldacci, S Lista, ML Manca, P Lemercier, PA Chiesa, H Zetterberg, ... Alzheimer's & Dementia 16, e041792, 2020 | 1 | 2020 |
| Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort QD Thomas, X Quantin, P Lemercier, C Chouaid, S Schneider, T Filleron, ... ESMO open 9 (6), 103473, 2024 | | 2024 |
| 179O Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER-positive, HER2-negative breast cancer harboring homologous recombination repair (HRR … S Guiu, J Balmaña, P Lemercier, P Follana, A Gonçalves, F Bigot, ... ESMO Open 9, 2024 | | 2024 |
